Industrial Development and Innovation: Some Lessons from Vaccine Procurement

World Development

Volumn 34, Issue 10, 2006, Pages 1742-1764

  Srinivas, Smita ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

developing countries; India; industrial development; innovation; local needs; standards and regulations; vaccines

Indexed keywords

DEVELOPING WORLD; HEALTH POLICY; INDUSTRIAL DEVELOPMENT; INDUSTRIAL POLICY; INNOVATION; SOCIAL IMPACT; STANDARD (REGULATION); VACCINE;

ASIA; EURASIA; INDIA; SOUTH ASIA;

EID: 33748445758     PISSN: 0305750X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.worlddev.2006.02.004     Document Type: Article

References (64)

1. Achilladelis B., and Antonakis N. The dynamics of technological innovation: the case of the pharmaceutical industry. Research Policy 30 (2001) 535-588
2. Achilladelis B., Robertson A.B., and Freeman C. Study on innovation in chemical industry-preliminary report on Project Sappho. Chemistry and Industry 10 (1971) 269
3. Archibugi D., and Bizarri K. Committing to vaccine R&D: A global science policy priority. Research Policy 33 10 (2004) 1657-1671
4. Arocena R., and Sutz J. Looking at national systems of innovation from the South. Industry and Innovation 7 1 (2000) 55-75
5. Arrow K.J. Economic welfare and the allocation of resources for invention. In: Nelson R.R. (Ed). The rate and direction of inventive activity (1962), Princeton University Press, Princeton, NJ, USA
6. Arrow K.J. The economic implications of learning by doing. Review of Economic Studies 29 3 (1962) 155-173 [ABS]
7. Bardhan P. The economic theory of Agrarian institution (1991), Clarendon Press, Oxford, UK
8. Bauer P. The development frontier-essays in applied economics (1991), Harvester-Wheatsheaf, London, UK
9. Bell M., and Pavitt K. Technological accumulation and industrial growth: Contrasts between developed and developing countries. Industrial and Corporate Change 2 2 (1993) 157-210
10. Bhagwati J.N. Directly unproductive, profit-seeking (DUP) activities. The Journal of Political Economy 90 5 (1982) 988-1002
11. Biospectrum, various volumes, September (2003), and October 2004, Gurgaon, Haryana, India.
12. Dalper R. Effects of government procurement of industrial innovation. Technology in Society 16 1 (1994) 65-83
13. De Fialho, B. C., & Srinivas, S. (2004). Science for local needs? Research and policy implications of national and international malaria efforts. STG Working Paper 2004-02, Science, technology and globalization project, Kennedy School of Government, Harvard University, June.
14. Dellepiane N., Griffiths E., and Milstien J.B. New challenges in assuring vaccine quality. Theme papers. Bulletin of the World Health Organization 78 2 (2000) 155-162
15. Dore R. Flexible rigidities: Industrial policy and structural adjustment in the Japanese economy 1970-1980 (1986), Stanford University Press, Palo Alto, CA, USA
16. In: Dosi G., Freeman C., Nelson R.R., Silverberg G., and Soete L. (Eds). Technical change and economic theory (1987), Pinter publishers, London, UK
17. Edquist C., and Hommen L. Systems of innovation: Theory and policy for the demand side. Technology in Society 21 (1999) 63-79
18. Gereffi G. The organization of buyer-driven global commodity chains: How US retailers shape overseas production networks. In: Gereffi G., and Korzeniewicz H. (Eds). Commodity chains and global capitalism (1994), Praeger Press, Westport, CT, USA 95-122
19. Hirschman A.O. The strategy of economic development (1961), Yale University Press, New Haven, CT, USA
20. International AIDS Vaccine Initiative (IAVI). When will an AIDS vaccine be found? The state of global research (2002), IAVI, New York, USA
21. Kaplinsky R., and Manning C. Concentration, competition policy and the role of small and medium-sized enterprises in South Africa's industrial development. Journal of Development Studies 35 1 (1998) 139-161
22. In: Kaul I., Conceicao P., Le Goulven K., and Mendoza R.U. (Eds). Providing public goods: Managing globalisation (2003), Oxford University Press, New York, USA
23. Kaul I., and Faust M. Global public goods and health: Taking the agenda forward. Bulletin of the World Health Organisation 79 9 (2001) 869-874
24. In: Kim L., and Nelson R.R. (Eds). Technology, learning and innovation (2000), Cambridge University Press, Cambridge, UK
25. Kremer M. Creating markets for new vaccines: Part II: Design issues. In: Jaffe A.B., Lerner J., and Stern S. (Eds). Innovation policy and the economy (2001), MIT Press, Cambridge, MA, USA
26. Krueger A.O. The political economy of the rent seeking society. American Economic Review 1974 64 (1974) 291-303
27. Kumar A. Medicine and the Raj: British medical policy in India, 1835-1911 (1998), Sage Publications, New Delhi, India
28. Kumaresan J., Smith I., Arnold V., and Evans P. Global TB drug facility: Innovative global procurement. International Journal of Tuberculosis and Lung Disease 8 1 (2004) 130-138
29. Lall S. International pharmaceutical industry and less-developed countries, with special reference to India. Oxford Bulletin of Economics And Statistics 56 3 (1974) 143-172
30. Lall, S. (1987). Learning to industrialize: The acquisition of technological capability by India. London, UK: Macmillan and New York, USA: St. Martin's Press.
31. Landes D.S. The unbound prometheus: Technological change and industrial development in Western Europe from 1750 to the present (1969), Cambridge University Press, Cambridge, UK
32. Lohray B. Medical biotechnology in India. Advances in Biochemical Engineering/Biotechnology, Volume 85/2003, Biotechnology in India II (2003), Springer, Berlin/Heidelberg, Germany 215-281
33. In: Lundvall B.A. (Ed). National systems of innovation: Towards a theory of innovation and interactive learning (1992), Pinter Publishers, London, UK
34. Lundvall B.A., and Johnson B. The learning economy. Journal of Industry Studies 1 2 (1994) 23-42
35. Madhavi Y. The manufacture of consent? Hepatitis B vaccination. Economic and Political Weekly 38 24 (2003) 2417-2424
36. Madhavi Y. Vaccine policy in India. Public Library of Science (PLoS Med) 2 5 (2005) e127
37. McKinney, S., & Jarrett, S. (2002). Update on vaccine security, SAGE/UNICEF/WHO, presentation June 14, 2002, http://www.who.int/vaccines-access/supply/Vaccine_security_Jarrett_McKinney.ppt. Last accessed February 11th 2005.
38. Milstien J.B., and Belgharbi L. Regulatory pathways for vaccines in developing countries. Bulletin of the World Health Organisation 82 2 (2004) 128-133
39. Milstien J.B., Gellin B.G., Kane M., Di Fabio J.L., and Homma A. Global DTP manufacturing capacity and capability. Status report: January 1995. Vaccine 14 4 (1996) 313-320
40. Milstien, J. B., Glass, S. N., Batson, A., Greco, M., & Berger, J. (2001). Divergence of vaccine product lines in industrialised and developing countries, unpublished manuscript. Presented to the Strategic Advisory Group of Experts 2001, Department of Vaccines and Biologicals, WHO.
41. Milstien J.B., Munira S.L., and McKinney S.L. Issues in selection of DTwP-based combination vaccines. Vaccine 21 15 (2003) 1658-1664
42. Mrazek M.F., and Mossialos E. Stimulating pharmaceutical research and development for neglected diseases. Health Policy 64 (2003) 75-88
43. Nelson R.R., and Winter S.G. An Evolutionary Theory of Economic Change (1982), Belknap Press of Harvard University Press, Cambridge, MA, USA
44. Phadke A., and Kale A. Some critical issues in the epidemiology of Hepatitis-B in India. Indian Journal of Gastroenterology 19 Suppl. 3 (2000) 76-77
45. PhRMA (2001). Industry profile 2001, http://www.phrma.org/publications/publications/profile01. Pharmaceutical Manufacturers Association, USA.
46. Rothwell R. Towards fifth-generation process innovation. International Marketing Review 11 1 (1994) 7-31
47. Sahu S.K. Technology transfer, dependence, and self-reliant development in the Third World: The pharmaceutical and machine tool industries in India (1998), Praeger Publishers, Westport, CT, USA
48. Schmitz H., and Cassiolato J. Hi-tech for industrial development. Lessons from the Brazilian experience in electronics and automation (1992), Routledge, London, UK
49. Schmitz H., and Knorringa P. Learning from global buyers. Journal of Development Studies 37 2 (2000) 177-205
50. Shafaeddin, M. (1998). How did developed countries industrialize? The history of trade and industrial policy: The cases of Great Britain and the USA. UNCTAD Discussion Paper No. 139, UNCTAD/OSG/DP/139, December.
51. Smith R.D., Woodward D., Acharya A., Beaglehole R., and Drager N. Communicable diseases control: A "Global Public Good" perspective. Health Policy and Planning 19 5 (2004) 271-278
52. Srinivas, S. (2004). Technological learning and the evolution of the Indian pharmaceutical and biopharmaceutical sectors. Unpublished doctoral dissertation, Massachusetts Institute of Technology, Cambridge, MA, USA, March.
53. Srinivas, S. (2005). Technical standards and economic development: Meeting the most common denominator. Paper prepared for the United Nations Industrial Development Organisation (UNIDO), Vienna.
54. Srinivas, S., & Sutz, J. (2005). Economic development and innovation: Problem-solving in scarcity conditions. Paper presented at the DRUID 10th anniversary conference, Copenhagen, Denmark, June.
55. Urban G.L., and von Hippel E. Lead user analyses for the development of new industrial products. Management Science 34 5 (1988) 569-582
56. Webber D., and Kremer M. Perspectives on stimulating industrial research and development for neglected infectious diseases. Bulletin of the World Health Organization 79 8 (2001) 735-741
57. Whitehead, P. (1999). Public sector vaccine procurement approaches: A discussion paper. Global Alliance for Vaccines and Immunisation (GAVI), Geneva, Switzerland (unpublished manuscript).
58. World Health Organization (WHO) (1995). Regulation and licensing of biological products. WHO Technical Report Series, No. 858.
59. WHO (1996). Investing in health research and development: Report of the Ad Hoc Committee on health research relating to future intervention options. WHO, Geneva, Switzerland.
60. WHO (1998). Guidelines for the international procurement of vaccines and sera, Vaccine supply and quality. Global programme for vaccines and immunization, WHO/VSQ/98.05.
61. WHO (2003a). Initiative for vaccine research (IVR), Vaccines, immunisation and biologicals, Database on contract manufacturers. Also, http://www.who.int/vaccines-access/quality/contractmanufdb/index.htm, updated February 4th, 2003.
62. WHO (2003b). Regional vaccine policy for South-East Asia Region. Regional Office for South-East Asia, New Delhi, India.
63. WHO (2005). http://www.who.int/vaccines-access/supply/specialaboutvacc.htm, accessed October 2005.
64. Woodle D. Vaccine procurement and self-sufficiency in developing countries. Health Policy and Planning 15 2 (2000) 121-129